Seoul Pharma Co., Ltd.

Seoul Pharma Co., Ltd.

Seoul Pharma Co., Ltd.

Overview
Date Founded

1976

Headquarters

No. 603, Shihwa Industrial Complex,59 Gyeongje-ro,Siheung, Gyeonggi 15093

Type of Company

Public

Employees (Worldwide)

215

Industries

Pharmaceuticals

Company Description

Seoul Pharma Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. Its products include drugs for cardiovascular system, respiratory and digestive system, antipyretic, analgesic, anti-inflammatory, antibacterial, anti-fungal, anti-viral, cream and ointment, anti-diabetic, anti-obesity, tonics, vitamins and minerals. The company was founded in 1976 and is headquartered in Cheongju, South Korea.

Executives & Employees

President, Chief Executive Officer & Director

Auditor

Director & Vice President

Director & Vice President

Board of Directors

Former Chief Executive Officer at JW Life Science

Former President, Chief Executive Officer & Director at CMG Pharmaceutical Co., Ltd.

Vice President, Head-Sales & Management at Sam-A Pharm Co., Ltd.

Former Auditor at Daewoong Bio, Inc.

Paths to Seoul Pharma Co., Ltd.
Potential Connections via
Relationship Science
You
Seoul Pharma Co., Ltd.
Clients

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Established in 1945, Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2015. Daewoong has maintained a steady growth rate in the double digits and has paid surplus dividends for the last 40 years. In addition to its product portfolio, which includes 16 blockbuster products, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners. In the future, Daewoong will expand its global business with its foreign branches and global partners and become a global healthcare group which contributes to improving the quality of life for people worldwide

Key Stats and Financials As of 2017
Market Capitalization
$85.3B
Total Enterprise Value
$104B
Earnings Per Share
$111
Revenue
$46.7B
Net Profit
$881M
Total Equity
$53.9B
EBITDAMargin
14.27%
Enterprise Value Sales
2.23x
Total Debt
$22B
EBITDA
$6.66B
Three Year Compounded Annual Growth Rate Of Revenue
2.11%
Five Year Compounded Annual Growth Rate Of Revenue
0.12%
Enterprise Value EBITDAOperating
15.65x
TEVNet Income
118.16x
Debt TEV
0.21x
Competitors
Korean Drug Co., Ltd. Pharmaceuticals - Icheon, GY

Korean Drug Co., Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. Its products are divided into the following categories: Over-The-Counter (OTC), ETC and Health Foods. Its products include remedies for respiratory diseases, topical agents for dermatoses, antibiotics and chemotherapeutics, hypnotics, antiulcer agents, antihistaminic, amino acid nutrients, antifungal agents and home pregnancy test kit. The company was founded on January 10, 1980 and is headquartered in Icheon, South Korea.

Jin Yang Pharmaceutical Co. Ltd. Pharmaceuticals - Seoul, SL

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business. Its products includes medicines for digestive system, respiratory system, antihistamines, antipyretics & analgesics, antimicrobials & antibiotics, muscle relaxants, neuropsychiatric system, anti-hypertensives, anti-hyperlipidemics, anti-diabetics, circulatory system, injections, dermatological system, multivitamins & nutritionals, anti-obesity, hepatics, anti-anemics, anti-osteoporosis, genito-urinary system, dental care drugs, and ophthalmic drugs. The company was founded on July 1, 1971 and is headquartered in Seoul, South Korea.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Seoul Pharma Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Seoul Pharma Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Seoul Pharma Co., Ltd..